What's in Behar, Caren, M.D.'s pipeline?

Behar, Caren, M.D. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Behar, Caren, M.D.'s portfolio?

Top competitors by shared drug class: American University of Beirut Medical Center, Amneal Pharmaceuticals, LLC, Antibe Therapeutics Inc., Apsen Farmaceutica S.A., AstraZeneca.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/behar-caren-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Behar, Caren, M.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behar, Caren, M.D. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Topical, intra-oral ketoprofen gel	Topical, intra-oral ketoprofen gel	phase 3	NSAID	COX-1, COX-2	Pain management
topical intraoral ketoprofen gel	topical intraoral ketoprofen gel	phase 3	NSAID		Oral Health

Therapeutic area mix

Oral Health · 1
Pain management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

American University of Beirut Medical Center · 1 shared drug class
Amneal Pharmaceuticals, LLC · 1 shared drug class
Antibe Therapeutics Inc. · 1 shared drug class
Apsen Farmaceutica S.A. · 1 shared drug class
AstraZeneca · 1 shared drug class
Chinese University of Hong Kong · 1 shared drug class
Generic (originally Syntex) · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Behar, Caren, M.D.:

Cite this brief

Drug Landscape (2026). Behar, Caren, M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/behar-caren-m-d. Accessed 2026-05-16.